Methods: Sixteen patients with solid malignancies were treated with a multitargeted receptor tyrosine kinase inhibitor, resulting
in a variety of responses.
0
comments
:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.